These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 6734031

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of cefamandole in patients with renal impairment.
    Czerwinski AW, Pederson JA.
    Antimicrob Agents Chemother; 1979 Feb; 15(2):161-4. PubMed ID: 426510
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of carumonam in patients with renal insufficiency.
    Horber F, Egger HJ, Weidekamm E, Dubach UC, Frey FJ, Probst PJ, Stoeckel K.
    Antimicrob Agents Chemother; 1986 Jan; 29(1):116-21. PubMed ID: 3729324
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. High-performance liquid chromatographic determination of cefonicid in human plasma and urine.
    Brendel E, Zschunke M, Meineke I.
    J Chromatogr; 1985 May 03; 339(2):359-65. PubMed ID: 4008574
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E, Mazzei T, Periti P, Reali EF, Bordonaro P, Balocchini E, Ninu B.
    Chemioterapia; 1987 Jun 03; 6(2 Suppl):243-6. PubMed ID: 3509398
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function.
    Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, Hara H, Nakamura S, Ushiogi Y, Kawabata M, Hashimoto N.
    Eur J Clin Pharmacol; 1985 Jun 03; 28(3):327-31. PubMed ID: 2861096
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.
    Boike SC, Pue MA, Freed MI, Audet PR, Fairless A, Ilson BE, Zariffa N, Jorkasky DK.
    Clin Pharmacol Ther; 1994 Apr 03; 55(4):418-26. PubMed ID: 8162668
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.
    Bliss M, Mayersohn M, Arnold T, Logan J, Michael UF, Jones W.
    Antimicrob Agents Chemother; 1986 Apr 03; 29(4):649-53. PubMed ID: 3707113
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cefamandole kinetics in uremic patients undergoing hemodialysis.
    Gambertoglio JG, Aziz NS, Lin ET, Grausz H, Naughton JL, Benet LZ.
    Clin Pharmacol Ther; 1979 Nov 03; 26(5):592-9. PubMed ID: 498702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.